RD6-2198, a novel betain-type fluoroalkylated oligomer, inhibits the replications of human immunodeficiency virus type 1 and other enveloped viruses

Antiviral Research

Volumn 38, Issue 2, 1998, Pages 141-149

  Fujiwara, Masatoshi ^a,d   Ashida, Noriyuki ^a   Okamoto, Masayuki ^a   Mizuta, Tadashi ^a   Ide, Teruhiko ^b   Hanasaki, Yasuaki ^b   Katsuura, Kimio ^b   Sawada, Hideo ^c   Shigeta, Shiro ^d   Konno, Kenji ^a   Yokota, Tomoyuki ^a   Baba, Masanori ^e  

^a Rational Drug Design Laboratories   (Japan)

^b TOSOH CORPORATION   (Japan)

^c NARA NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e Ctr Chron Viral Dis Fac M   (Japan)

Author keywords

Fluoroalkylated oligomer; HIV 1; HSV 1; HSV 2; RSV; Viral adsorption inhibitor

Indexed keywords

BETAINE; CD4 ANTIGEN; DEXTRAN SULFATE; GLYCOPROTEIN GP 120; OKT 4; OLIGOMER; RD 6 2198; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG POTENCY; DRUG SELECTIVITY; EMBRYO; FEMALE; HELA CELL; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LUNG FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TOPICAL DRUG ADMINISTRATION; VAGINITIS; VIRUS ADSORPTION; VIRUS INHIBITION;

EID: 0031819352     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(98)00022-9     Document Type: Article

References (23)

1. Abrams D.I., Kuno S., Wong R., Jeffords K., Nash M., Molaghan J.B., Gorther R., Ueno R. Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann. Intern. Med. 110:1989;183-188.
2. Baba M., Schols D., Pauwels R., Balzarini J., De Clercq E. Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Biochem. Biophys. Res. Commun. 155:1988;1404-1411.
3. Baba M., Pauwels R., Balzarini J., Arnout J., Desmyter J., De Clercq E. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immnodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA. 85:1988;6132-6136.
4. Baba M., Schols D., Pauwels R., Nakashima H., De Clercq E. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy. J. Acquir. Immun. Defic. Syndr. 3:1990;493-499.
5. Baba M., Kira T., Shigeta S., Matsumoto T., Sawada H. Selective inhibition of human immunodeficiency virus type 1 replication by novel fluoroalkylated oligomers in vitro. J. Acquir. Immun. Defic. Syndr. 7:1994;24-30.
6. Baba M., Shigeta S., Yuasa S., Takashima H., Sekiya K., Ubasawa M., Tanaka H., Miyasaka T., Walker R.T., De Clercq E. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. Antimicrob. Agents Chemother. 38:1994;688-692.
7. Balzarini J., Mitsuya H., De Clercq E., Broder S. Aurintricarboxylic acid and evans blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Biochem. Biophys. Res. Commun. 136:1986;64-71.
8. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nature Med. 3:1997;42-47.
9. De Jong J.-J., Goudsmit J., Keulen W., Klaver B., Krone W., Tersmette M., De Ronde A. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:1992;757-765.
10. Fujiwara M., Ijichi K., Tokuhisa K., Katsuura K., Wang G.-Y.-S., Uemura D., Shigeta S., Konno K., Yokota T., Baba M. Ingenol derivatives are highly potent and selective inhibitors of HIV replication in vitro. Antiviral Chem. Chemother. 7:1996;230-236.
11. Hashimoto K., Kodama E., Mori S., Watanabe J., Baba M., Okutani K., Matsuda M., Shigeta S. Antiviral activity of a sulphated polysaccharide extracted from the marine Pseudomonas and marine plant Dinoflagellata against human immunodeficiency viruses and other enveloped viruses. Antiviral Chem. Chemother. 7:1996;189-196.
12. Jiang S. HIV-1-co-receptors binding. Nature Med. 3:1997;367-368.
13. Mahmood N., Pizza C., Aquino R., De Tommasi N., Piacente S., Colman S., Burke A., Hay A.J. Inhibition of HIV infection by flavanoids. Antiviral Res. 22:1993;189-199.
14. Meylan P.R.A., Kornbluth R.S., Zbinden I., Richman D.D. Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds. Antimicrob. Agents Chemother. 38:1994;2910-2916.
15. Neyts J., De Clercq E. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10:1995;8-12.
16. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter J., De Clercq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods. 20:1988;309-321.
17. Phillips D.M. The role of cell-to-cell transmission in HIV infection. AIDS. 8:1994;719-731.
18. Sawada, H., Katayama, S., Nakamura, Y., Kawase, T., Hayakawa, Y., Baba, M., 1998. Gelation of fluoroalkylated 2-acrylamido-2-methylpropanesulfonic acid oligomers as potential for prevention of HIV-1 transmission. Polymer, 39, 743-746.
19. Schols D., Baba M., Pauwels R., Desmyter J., De Clercq E. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc. Natl. Acad. Sci. USA. 86:1989;3322-3326.
20. Schols D., De Clercq E., Balzarini J., Baba M., Witvrouw M., Hosoya M., Andrei G., Snoeck R., Pauwels R., Nagy M., Gyorgyi-Edelenyi J., Machovich R., Horvath I., Low M., Gorog S. Sulfated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, arena-, and retro-viruses. Antiviral Chem. Chemother. 4:1990;233-240.
21. Sudo K., Konno K., Yokota T., Shigeta S. A sensitive assay system screening antiviral compounds against herpes simplex virus type 1 and type 2. J. Virol. Methods. 49:1994;169-178.
22. Watanabe W., Konno K., Ijichi K., Inoue H., Yakota T., Shigeta S. MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents. J. Virol. Methods. 48:1994;257-265.
23. Witvrouw M., Este J.A., Mateu M.Q., Reyman D., Andrei G., Snoeck R., Ikeda S., Pauwels R., Bianchini N.V., Desmyter J., De Clercq E. Activity of a sulfated polysaccharide extracted from the red seaweed Aghardhiella tenera against human immunodeficiency virus and other enveloped viruses. Antiviral Chem. Chemother. 5:1994;297-303.